Physician profile
James G Barrios
NPI 1366839490
$43,101.86
in general payments reported to CMS, 2019-2025
19 companies · $2,443 in 2025
The $2,443 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2021: $252 · 2022: $7,452 · 2023: $25K · 2024: $7,502 · 2025: $2,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $22K · Food and Beverage: $7,876 · Travel and Lodging: $4,833 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,393.94 |
| Food and Beverage | $7,875.70 |
| Travel and Lodging | $4,833.45 |
| Education | $144.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,994.37 | 2019-2025 | Ensite Precision, Aveir, Gallant |
| Boston Scientific Corporation | $13,217.35 | 2023-2025 | S-Icd System Magnet, Watchman Access System, Emblem Mri S-Icd |
| Medtronic, INC. | $7,259.25 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Biosense Webster, INC. | $749.09 | 2023-2025 | Carto 3 |
| Biotronik INC. | $264.66 | 2024-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Kestra Medical Technology Services, INC. | $133.49 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.12 | 2024-2025 | Lifevest |
| Pfizer INC. | $82.63 | 2021-2025 | |
| Novo Nordisk INC | $58.40 | 2025 | Wegovy |
| Baxter Healthcare | $44.10 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Atricure, INC. | $33.39 | 2024 | |
| Novartis Pharmaceuticals Corporation | $32.52 | 2025 | |
| Cardiva Medical, INC. | $31.16 | 2025 | Ensoetm |
| Abiomed | $27.02 | 2024 | Impella |
| Cordis US Corp. | $20.32 | 2024 | Mynx Venous Vcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $18.79 | 2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.13 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.08 | 2021 | |
| Vital Connect, INC | $13.99 | 2024 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barrios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.